re: revenue and growth - kopiteau Allotment of shares to institutions is quick and easy.
Providing not "largish" dilution and not too underpriced should not be significant change to shareholders value.
What is done with the fund-raising is critical.
If fritted away 'tis a very poor result.
If used in a positive manner is very positive.
The "show me the money first" institution approach to valuing companies is a critical issue with PBI.
May show all the promise in the world - but promises are speculation and institutions are loath to place value on speculative qualities of shares.
They need tangible valuations, actual contracts, actual profits, projected profits based on reliable information.
Do not expect PBI share price to climb until institutions have these factors to calculate with.
When a profitable contract is achieved and institutions can varify a positive future cash flow share price will react accordingly.
Naturally "insiders" may push price in anticipation of such a development.
PBI may be negotiating for commercial use of products.
To achieve maximum benefits for shareholders.
With watertight legally well structured contracts.
The other party will be negotiating a maximum benefit, watertight, legally well structured contract too.
For their shareholders.
Either party may withdraw at any time.
And when this happens PBI must commence negotiations with another party and the protracted process commences again.
Bluff and negotiation must be part of the process.
While this is happening PBI management are not in a position to make any statements to markets.
So could be thought to be lacking in action and lacking in disclosure.
Unfairly!
The bottom line is that if PBI is to do justice for shareholders time and lack of information to the market is inevitable.
Shareholders therefore must wait for some time - patiently.
Show ME the money!!!
Cheers,
NT
- Forums
- ASX - By Stock
- revenue and growth
PBI
premier bionics limited
re: revenue and growth - kopiteau Allotment of shares to...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PBI (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online